Novo Nordisk's Wegovy improves kidney health in patients with obesity (NYSE:NVO) by Technical Terrence Team 05/25/2024 0 hapabapa/iStock Editorial via Getty Images Novo Nordisk's (NVO) anti-obesity therapy Wegovy reduced kidney-related adverse events by 22% in overweight and ...
US FDA panel votes against Novo Nordisk's weekly insulin in patients with type 1 diabetes By Reuters by Technical Terrence Team 05/24/2024 0 By Sriparna Roy and Mariam Sunny (Reuters) - Advisers to the U.S. health regulator voted on Friday against the use ...